Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
LGBTQ+
Research
White House orders NIH to study trans 'regret': reports
Historically, regret rates for gender-affirming surgeries have been around 1%, much lower than other surgical procedures.
Darren Incorvaia
Apr 11, 2025 3:00pm
NIH cancels a number of LGBTQ+ health research grants: report
Mar 5, 2025 6:00am
Execs fight 'actively harmful' bans on gender-affirming care
Jun 27, 2023 5:00am
Twist is doing better than most on ESG, but opportunities remain
Jan 31, 2022 4:45pm
2022 forecast: Will trials be less white next year?
Dec 22, 2021 3:00am
Fierce Biotech's top 10 editor's picks for 2021
Dec 21, 2021 9:00am
